What is Beam Therapeutics's earnings yield?

Beam Therapeutics (BEAM) reported earnings yield of -16.9% in Q3 2025.

What is the long-term trend for Beam Therapeutics's earnings yield?

Over 3 years (2020 to 2024), Beam Therapeutics's earnings yield has grown at a 73.7% compound annual growth rate (CAGR), from -3.5% to -18.3%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Beam Therapeutics BEAM Earnings yield

Earnings yield at other companies

Vertex PharmaceuticalsVRTX

3.8%—

Arrowhead ResearchARWR

-3.4%-1.3pp

Ultragenyx PharmaceuticalRARE

-29.6%+144pp

MGN

MagniteMGNI

9.3%+7.4pp

Intellia TherapeuticsNTLA

-26.1%-10.1pp

CRISPR TherapeuticsCRSP

-12.5%-0.7pp

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.42B+24.5%

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Calculated from Beam Therapeutics’s reported figures.

net income/market cap=-16.9%

Based on trailing twelve months.

The official record: Beam Therapeutics’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's earnings yield?: Beam Therapeutics (BEAM) reported earnings yield of -16.9% in Q3 2025.
What is the long-term trend for Beam Therapeutics's earnings yield?: Over 3 years (2020 to 2024), Beam Therapeutics's earnings yield has grown at a 73.7% compound annual growth rate (CAGR), from -3.5% to -18.3%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.